SCHEMBL20156026

SCHEMBL20156026

CCOC(=O)/C(C=N)=C/NCC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CYP2D6 P10635 2/20 0.49
GLO1 Q04760 1/20 0.38
EGLN1 Q9GZT9 1/20 0.36
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
DHODH Q02127 3/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 3/20 0.32
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
FAAH O00519 2/20 0.31
CYP3A4 P08684 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24886301 0.84 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL20156006 0.84 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL23912850 0.81 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2CYP2D6GLO1MAPT
SCHEMBL14838887 0.79 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL23953799 0.74 NPSR1 (0.43) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL20156005 0.73 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2CYP2D6GLO1
SCHEMBL14346035 0.72 NPSR1 (0.42) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL27379728 0.71 MAPT (0.37) ALDH1A1SMN1; SMN2CYP2D6MAPTNPSR1
SCHEMBL16410842 0.71 NPSR1 (0.41) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1
SCHEMBL15166437 0.71 NPSR1 (0.41) ALDH1A1SMN1; SMN2CYP2D6GLO1EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed